Clinuvel Pharmaceuticals | CUV - Ebitda

Stock Price
11.79
Daily Change
0.58 5.17%
Monthly
-5.15%
Yearly
1.99%
Q1 Forecast
10.78

Clinuvel Pharmaceuticals reported AUD27.55M in EBITDA for its fiscal semester ending in June of 2025.





Ebitda Change Date
Avita Medical AUD -21.9M 12.04M Jun/2025
Medical Developments International AUD 1.78M 3.78M Dec/2024
Mesoblast USD -17.78M 17.03M Jun/2025
Neuren Pharmaceuticals AUD 176.7M 166.79M Dec/2024
Pacific Edge NZD -13.97M 332K Sep/2024
Paradigm Biopharmaceuticals AUD -5.86M 3.79M Dec/2024
PYC Therapeutics AUD -24.29M 1.3M Jun/2025
Telix Pharmaceuticals AUD 33.24M 6.5M Jun/2025